<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Predicting Response to Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia Using Structural Magnetic Resonance Imaging: A Multisite Machine Learning Analysis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-08-31">August 31, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Nikolaos</forename><surname>Koutsouleris</surname></persName>
							<email>nikolaos.koutsouleris@med.uni-muenchen.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution" key="instit1">Klinikum der Universität München</orgName>
								<orgName type="institution" key="instit2">Ludwig-Maximilians-Universität</orgName>
								<address>
									<settlement>Munich</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Wobrock</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">Georg-August-University Goettingen</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">County Hospitals Darmstadt-Dieburg, Groß-Umstadt</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Birgit</forename><surname>Guse</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">Georg-August-University Goettingen</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Berthold</forename><surname>Langguth</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">University of Regensburg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Landgrebe</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">University of Regensburg</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Psychiatry, Psychosomatics and Psychotherapy</orgName>
								<orgName type="institution">kbo-Lech-Mangfall-Klinik Agatharied</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Eichhammer</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">University of Regensburg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elmar</forename><surname>Frank</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">University of Regensburg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joachim</forename><surname>Cordes</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">Heinrich-Heine University</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wolfgang</forename><surname>Wölwer</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">Heinrich-Heine University</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Francesco</forename><surname>Musso</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">Heinrich-Heine University</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Georg</forename><surname>Winterer</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Experimental &amp; Clinical Research Center (ECRC)</orgName>
								<orgName type="institution">Charite -University Medicine Berlin</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wolfgang</forename><surname>Gaebel</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">Heinrich-Heine University</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Göran</forename><surname>Hajak</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">European Clinical Research Infrastructure Network (ECRIN)</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Ohmann</surname></persName>
							<affiliation key="aff9">
								<orgName type="laboratory">Coordination Centre for Clinical Trials</orgName>
								<orgName type="institution">Heinrich-Heine University</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Pablo</forename><forename type="middle">E</forename><surname>Verde</surname></persName>
							<affiliation key="aff9">
								<orgName type="laboratory">Coordination Centre for Clinical Trials</orgName>
								<orgName type="institution">Heinrich-Heine University</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marcella</forename><surname>Rietschel</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Department of Genetic Epidemiology in Psychiatry</orgName>
								<orgName type="department" key="dep2">Medical Faculty Mannheim</orgName>
								<orgName type="institution" key="instit1">Institute of Central Mental Health</orgName>
								<orgName type="institution" key="instit2">University of Heidelberg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Raees</forename><surname>Ahmed</surname></persName>
							<affiliation key="aff11">
								<orgName type="institution" key="instit1">Referat Klinische Studien Management</orgName>
								<orgName type="institution" key="instit2">Georg-August-University Goettingen</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">William</forename><forename type="middle">G</forename><surname>Honer</surname></persName>
							<affiliation key="aff12">
								<orgName type="institution" key="instit1">Institute of Mental Health</orgName>
								<orgName type="institution" key="instit2">The University of British Columbia</orgName>
								<address>
									<settlement>Vancouver</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dominic</forename><surname>Dwyer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution" key="instit1">Klinikum der Universität München</orgName>
								<orgName type="institution" key="instit2">Ludwig-Maximilians-Universität</orgName>
								<address>
									<settlement>Munich</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Farhad</forename><surname>Ghaseminejad</surname></persName>
							<affiliation key="aff12">
								<orgName type="institution" key="instit1">Institute of Mental Health</orgName>
								<orgName type="institution" key="instit2">The University of British Columbia</orgName>
								<address>
									<settlement>Vancouver</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Dechent</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Department of Cognitive Neurology</orgName>
								<orgName type="institution">Georg-August-University Goettingen</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Berend</forename><surname>Malchow</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution" key="instit1">Klinikum der Universität München</orgName>
								<orgName type="institution" key="instit2">Ludwig-Maximilians-Universität</orgName>
								<address>
									<settlement>Munich</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">M</forename><surname>Kreuzer</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">University of Regensburg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tim</forename><forename type="middle">B</forename><surname>Poeppl</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution">University of Regensburg</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Schneider-Axmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution" key="instit1">Klinikum der Universität München</orgName>
								<orgName type="institution" key="instit2">Ludwig-Maximilians-Universität</orgName>
								<address>
									<settlement>Munich</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Falkai</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution" key="instit1">Klinikum der Universität München</orgName>
								<orgName type="institution" key="instit2">Ludwig-Maximilians-Universität</orgName>
								<address>
									<settlement>Munich</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alkomiet</forename><surname>Hasan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution" key="instit1">Klinikum der Universität München</orgName>
								<orgName type="institution" key="instit2">Ludwig-Maximilians-Universität</orgName>
								<address>
									<settlement>Munich</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="laboratory">Coordination Centre for Clinical Trials</orgName>
								<orgName type="institution">Heinrich-Heine-University</orgName>
								<address>
									<settlement>Düsseldorf)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="department">Department of Psychiatry and Psychotherapy</orgName>
								<orgName type="institution" key="instit1">Neurodiagnostic Applications in Psychiatry</orgName>
								<orgName type="institution" key="instit2">Ludwig-Maximilian-University</orgName>
								<address>
									<addrLine>Nussbaumstr. 7</addrLine>
									<postCode>D-80336</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Predicting Response to Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia Using Structural Magnetic Resonance Imaging: A Multisite Machine Learning Analysis</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-08-31">August 31, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">D0A4EEF9FDB19ED23F65F4122F025134</idno>
					<idno type="DOI">10.1093/schbul/sbx114</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:31+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>schizophrenia</term>
					<term>repetitive transcranial magnetic stimulation</term>
					<term>neuroanatomical pattern classification</term>
					<term>machine learning</term>
					<term>voxel-based morphometry</term>
					<term>treatment outcome prediction</term>
					<term>response heterogeneity</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: The variability of responses to plasticityinducing repetitive transcranial magnetic stimulation (rTMS) challenges its successful application in psychiatric care.</s><s>No objective means currently exists to individually predict the patients' response to rTMS.</s><s>Methods: We used machine learning to develop and validate such tools using the pre-treatment structural Magnetic Resonance Images (sMRI) of 92 patients with schizophrenia enrolled in the multisite RESIS trial (http://clinicaltrials.gov, NCT00783120): patients were randomized to either active (N = 45) or sham (N = 47) 10-Hz rTMS applied to the left dorsolateral prefrontal cortex 5 days per week for 21 days.</s><s>The prediction target was nonresponse vs response defined by a ≥20% pre-post Positive and Negative Syndrome Scale (PANSS) negative score reduction.</s><s>Results: Our models predicted this endpoint with a cross-validated balanced accuracy (BAC) of 85% (nonresponse/response: 79%/90%) in patients receiving active rTMS, but only with 51% (48%/55%) in the sham-treated sample.</s><s>Leave-site-out cross-validation demonstrated cross-site generalizability of the active rTMS predictor despite smaller training samples (BAC: 71%).</s><s>The predictive pre-treatment pattern involved gray matter density reductions in prefrontal, insular, medio-temporal, and cerebellar cortices, and increments in parietal and thalamic structures.</s><s>The low BAC of 58% produced by the active rTMS predictor in sham-treated patients, as well as its poor performance in predicting positive symptom courses supported the therapeutic specificity of this brain pattern.</s><s>Conclusions: Individual responses to active rTMS in patients with predominant negative schizophrenia may be accurately predicted using structural neuromarkers.</s><s>Further multisite studies are needed to externally validate the proposed treatment stratifier and develop more personalized and biologically informed rTMS interventions.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Repetitive transcranial magnetic stimulation (rTMS) offers unique possibilities for the induction of long-term excitability and plasticity changes at the neural-systems level. <ref type="bibr" target="#b0">1</ref> Due to these plasticity-inducing properties, rTMS has been systematically evaluated as a novel treatment option for various neuropsychiatric disorders.</s><s>]<ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref> This heterogeneity may result from genetic, <ref type="bibr" target="#b13">14</ref> neuroanatomical, <ref type="bibr" target="#b14">15</ref> neurofunctional, <ref type="bibr" target="#b15">16</ref> connectivity-based, <ref type="bibr" target="#b16">17</ref> and sociodemographic factors <ref type="bibr" target="#b17">18</ref> mediating the variability of rTMS effectiveness, but none can yet explain the large variability observed at the single-patient level.</s><s>The discovery and validation of such rTMS response predictors operating reliably in the individual patient could increase effectiveness and broad applicability of rTMS.</s><s>Furthermore, identifying neuromarkers of rTMS-related treatment outcomes may elucidate pathophysiological mechanisms that control impaired neural plasticity in mental disorders, <ref type="bibr" target="#b18">19</ref> thus propelling biologically informed, and hence more targeted noninvasive brain stimulation strategies.</s></p><p><s>Using longitudinal structural neuroimaging, we recently showed that outcome heterogeneity may emerge from the affected brain's varying capacity to structurally adapt hippocampal-precuneal brain networks following a plasticity-inducing rTMS intervention. <ref type="bibr" target="#b19">20</ref></s><s>This observation may point to a link between the longitudinal variability of treatment-induced dynamic brain changes and the cross-sectional structural and functional brain heterogeneity of the "group of schizophrenias". <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref></s><s>Recently, this heterogeneity has been decomposed using cognitive and electrophysiological clustering, revealing distinct biotypes associated with different degrees of clinical impairment and structural brain alterations. <ref type="bibr" target="#b22">23</ref></s><s>Similarly, a recent study deconvolving depression into 4 biotypes by clustering resting-state functional MRI data showed that these biotypes confer highly different response likelihoods to rTMS. <ref type="bibr" target="#b23">24</ref></s><s>Hence, these links between cross-sectional heterogeneity and therapeutic outcome variability raise the intriguing possibility that pre-treatment neuroanatomical signatures may be harnessed to predict rTMS-induced treatment outcomes in patients with severe mental illnesses.</s></p><p><s>Machine learning applied to the baseline structural Magnetic Resonance Images (sMRI) of patients with major depression has already demonstrated potential to predict response to electro-convulsive therapy (ECT) at the single-subject level. <ref type="bibr" target="#b24">25</ref></s><s>Similarly, pattern recognition techniques were recently reported to successfully predict therapeutic outcomes of ECT in patients with schizophrenia using resting-state functional MRI. <ref type="bibr" target="#b25">26</ref></s><s>In contrast to classical univariate statistics, machine learning algorithms can sift the complex brain patterns underlying neuropsychiatric disorders for clinically relevant predictive fingerprints. <ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28</ref></s><s>However, major unresolved challenges question these translational claims, particularly concerning the current lack of investigations assessing the proposed biomarkers' specificity for chosen treatment and outcome endpoints based on randomized clinical trial designs, or validating their generalizability across sites, scanners, and populations. <ref type="bibr" target="#b28">29</ref></s><s>ased on the currently largest study database of patients who received "Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia (RESIS)," <ref type="bibr" target="#b5">6</ref> we tested for the first time whether machine learning enables the single-subject prediction of rTMS-induced therapeutic responses in schizophrenia with predominant negative symptoms based on single-timepoint sMRI data recorded prior to treatment start.</s><s>Leveraging the multisite, randomized, double-blinded, placebo-controlled, multiple-timepoint design of the RESIS trial, <ref type="bibr" target="#b5">6</ref> we probed the proposed models' treatment and outcome specificity, their temporal stability in differentiating good vs poor responders, as well as their leave-site-out generalizability.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Subjects and Endpoints for Individualized Prediction</head><p><s>Patients with an ICD-10 diagnosis of schizophrenia enrolled in RESIS met the following criteria: Positive and Negative Syndrome Scale (PANSS) Negative Subscore (PANSS-NS) &gt; 20 points, 1 PANSS-NS item ≥4, no PANSS-NS reduction ≥10% in the 14 days before treatment start, and an illness duration of ≥1 year. <ref type="bibr" target="#b5">6</ref></s><s>From the Intention-To-Treat (ITT) population (N = 157), 96 patients had pre-treatment sMRI (active/sham rTMS: N = 45/47) and primary PANSS-NS outcome endpoints defined as follows <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b29">30</ref> : ∆PANSS-NS% = (PANSS-NS T1 -PANSS-NS T0 ) * 100/(PANSS-NS T0 -7).</s><s>PANSS-NS response was defined as ≥20% improvement between baseline and day 21. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b29">30</ref></s><s>Accordingly, patients were assigned to response or nonresponse groups, with assignments serving as targets for the machine learning analyses.</s><s>The same approach defined a PANSS positive (PANSS-PS) endpoint based on the respective pre-post score change.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Intervention</head><p><s>Patients received either 10 Hz active or sham rTMS applied to the left DLPFC according to the EEG-10-20 system (F3-electrode, 5 sessions/wk during the 3-week period, 1000 stimuli/d, 50 stimuli/train) with 110% of the individual resting motor threshold (RMS). <ref type="bibr" target="#b5">6</ref></s><s>Clinical data were recorded before stimulation (baseline/T0) and after day 21 (T1), day 28 (T2), day 45 (T3) and day 105 (T4) (supplementary figure <ref type="figure" target="#fig_1">1</ref>).</s><s>As reported previously, in the ITT population no significant differences in the primary outcome, other clinical outcomes and cognition could be detected between active and sham rTMS. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b8">9</ref></s><s>euromarkers of Response to rTMS in Schizophrenia</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MRI Imaging Data Acquisition and Processing</head><p><s>Structural MR images were obtained on two 3T systems (Siemens Trio) and one 1.5T system (Siemens Sonata) using T1-weighted sequences. <ref type="bibr" target="#b19">20</ref></s><s>All images were quality-controlled (N.K.) and 4 subjects had to be removed due to poor image quality.</s><s>The sMRI of the remaining 92 patients underwent automated tissue segmentation and high-dimensional stereotactic registration with Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra (DARTEL), <ref type="bibr" target="#b31">31</ref> producing gray matter density (GMD) images registered to the MNI-152 template and smoothed with an 8 mm Gaussian kernel.</s><s>We did not modulate the GMD images with the Jacobian determinants obtained from DARTEL as this step may decrease the sensitivity of voxel-based morphometry to detect mesoscopic brain alterations due to "multiplicative noise," ie, the interindividual macroscopic brain shape differences captured by the Jacobian determinants. <ref type="bibr" target="#b32">32</ref></s><s>e tested the effects of modulation in a supplementary analysis (see below).</s><s>Further image acquisition and preprocessing details are described in the supplementary methods.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Neuroanatomical Pattern Classification</head><p><s>We generated 3 overall predictive models using our freely available machine learning tool NeuroMiner (https://www.pronia.eu/neurominer/):</s><s>one to predict the PANSS-NS response criterion in patients receiving active rTMS, and-to validate model specificityone to predict this endpoint in sham-treated patients, and a third model to predict PANSS-PS outcomes in active rTMS.</s><s>As in our previous work <ref type="bibr" target="#b33">33,</ref><ref type="bibr" target="#b34">34</ref> and recommended for predictive modeling, <ref type="bibr" target="#b35">35</ref> we employed repeated nested cross-validation with 10 permutations × 20 folds at the outer cross-validation cycle, and 1 × 19 folds at the inner cycle to prevent information leaking between patients used for training, testing, and validating our models.</s><s>This enabled the unbiased estimation of these models' generalizability to new patients.</s><s>Following preprocessing steps were applied to each inner partition of the nested crossvalidation cycle (supplementary methods): First, the GMD training data were standardized based on their voxel-level mean and SDs.</s><s>Standardized data were site-adjusted using an established multivariate correction method <ref type="bibr" target="#b36">36</ref> : Principal Component Analysis (PCA) reduced the training patients' standardized GMD images to 20-25 principal components (PCs), accounting for 80% of the variance in the images. <ref type="bibr" target="#b37">37</ref></s><s>hen, analysis of variance (ANOVA) fitted 3 predictors encoding the training subjects' site membership to their loadings on each PC.</s><s>PCs explaining the siteencoding design matrix with R 2 &gt; .</s><s>16 were removed from the training data.</s><s>Finally, processed training data were scaled feature-wise from 0 to 1.</s><s>Then, standardization, PCA-based dimensionality reduction, PC removal, and scaling parameters were applied to the respective test and validation subjects' data.</s></p><p><s>In each training sample, we used the linear Support Vector Machine (SVM) <ref type="bibr" target="#b38">38,</ref><ref type="bibr" target="#b39">39</ref> to detect a decision boundary that predicted patients' outcome class in given rTMS treatment arm using their site-adjusted PCA scores.</s><s>All SVM models originating from an inner-cross validation cycle were then combined into an ensemble predictor, <ref type="bibr" target="#b40">40</ref> which was applied to the respective outercycle validation patients.</s><s>This process was repeated across all outer-cycle partitions of the repeated nested cross-validation design and for each validation patient the obtained SVM decision scores were integrated into a probabilistic ensemble prediction using majority voting.</s><s>The GMD baseline signature predicting subsequent response vs nonresponse to active rTMS was described in figure <ref type="figure" target="#fig_1">1</ref>.</s></p><p><s>We performed additional analyses to test model significance, generalizability and therapeutic specificity: First, we determined whether the observed prediction performances of the active and sham predictors significantly differed from a null distribution of the respective outcome labels by training and cross-validating SVM models on n = 1000 random label permutations. <ref type="bibr" target="#b41">41</ref></s><s> , where</s></p><formula xml:id="formula_0">BAC sensitivity specificity = + ( ) 2</formula><p><s>. Second, we assessed the models' generalizability by implementing a leave-siteout (LSO) approach: each of the 3 study sites was iteratively held back for validation, while the remaining data entered the inner cross-validation cycles.</s><s>We observed that the LSO classifiers showed lower prediction performances in the active rTMS condition than the pooled classifier (table <ref type="table" target="#tab_2">2</ref>).</s><s>Neuroanatomical outcome probabilities and Receiver-Operating Characteristics (ROC) plots generated by the 3 LSO classifiers on the held-back sites are presented in figure <ref type="figure" target="#fig_2">2B</ref> along with the respective charts of the pooled cross-validation experiment (figure <ref type="figure" target="#fig_2">2A</ref>).</s><s>To assess whether this performance drop was due to residual site effects, or, alternatively due to the lower training sample sizes available in the LSO experiments, we trained LSO predictors on n = 1000 permutations of the patients' site memberships.</s><s>We rejected the null hypothesis of original LSO predictors having an equal or higher prediction performance than the permuted predictors at α = .05,</s><s>where</s></p><formula xml:id="formula_1">P n i n = ≥ ( ) = = ∑ BAC B AC LSO L SO observed p ermuted / 1 1000</formula><p><s>. Third, we tested the treatment and outcome specificity of the active rTMS predictor, by measuring its prediction performance in sham-treated patients, and by comparing it against the PANSS-PS outcome predictor.</s><s>Further supplementary analyses were carried out in the active rTMS group to explore whether the analysis of (1) global gray matter, white matter, cerebrospinal fluid, and total intracranial volumes, or (2) modulated voxel-level GMD maps provided similar predictive performance as the analysis of unmodulated, voxel-level GMD maps (supplementary figure <ref type="figure">5</ref> and supplementary table <ref type="table" target="#tab_4">3</ref>).</s><s>In addition, we assessed whether standard mass-univariate analysis methods detected a similar pattern of GMD differences between nonresponders vs responders as the multivariate pattern recognition pipeline described above (supplementary figure <ref type="figure">6</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Post hoc Analyses</head><p><s>As only the active rTMS outcome prediction model was significant in the permutation analysis (see Results section), we performed a series of post-hoc analyses using SPSS 23 (IBM; significance level: α = .05)</s><s>to evaluate (1) how well the patients' neuroanatomical nonresponse likelihoods generated by this classifier predicted their continuous PANSS score changes measured between T0 and T1, and (2) whether the classifier's stratification effect observed at T1 delineated rTMS after-effects that extended to the T3 and T4 time points.</s><s>For the former analysis, we calculated the Spearman's ρ correlation between the patients' neuroanatomical nonresponse likelihoods and PANSS-NS change scores (figure <ref type="figure" target="#fig_3">3A</ref>).</s><s>For the latter, we performed a linear mixed model analysis by modeling the effects of the within-subject factor "TIME" (T0, T3 and T4) and the fixed between-subject factor "PREDICTED OUTCOME" (response vs nonresponse prediction) on the dependent PANSS-NS score variable.</s><s>We did not include the T1 (day 21) and T2 (day 28) examinations into the mixed model to avoid re-fitting the predicted outcome trajectories to the target endpoint of the machine learning analysis and its closest follow-up interval (1-wk difference).</s><s>The factor "'SITE" was entered as random factor in the design.</s><s>Additionally, we assessed the specificity of the PANSS-NS outcome predictor's longitudinal stratification effect by comparing it against mixed models which used the PANSS positive, GAF, and MADRS scores at T0, T3 and T4, instead of the PANSS-NS as dependent variables (supplementary analyses).</s><s>Finally, we performed a supplementary regression analysis to explore whether the neuroanatomical response likelihoods of the patients randomized to active rTMS were significantly (α = .05)</s><s>associated with the longitudinal hippocampal-precuneal volume increases reported previously. <ref type="bibr" target="#b19">20</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Sociodemographic and Clinical Data PANSS-NS did not differ between treatment groups at baseline and at T1 (t (90) ≤ 0.853, P ≥ .396)</s><s>as previously shown in the ITT population. <ref type="bibr" target="#b5">6</ref></s><s>Similarly, we did find not find other clinical baseline differences except for higher PANSS-PS scores in active rTMS and similar trend effects in the PANSS general and PANSS total scores ( , P = .989).</s><s>PANSS-PS scores were significantly higher in the active rTMS condition at baseline (t (87) = 2.565, P = .012),</s><s>but not at day 21 (t (87) = 0.876, P = .383). <ref type="bibr" target="#b5">6</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Neuroanatomical Prediction Performance</head><p><s>The MRI-based outcome classifier trained on the active rTMS group correctly separated PANSS-NS nonresponders from responders with a cross-validated balanced accuracy (BAC; sensitivity, specificity) of 84.8% (79.2%, 90.2%; table 2), resulting in Area-Under-the-Curve of 0.92 (figure <ref type="figure" target="#fig_2">2</ref>) and a positive Likelihood Ratio of 8.3.</s><s>Hence, a positive/negative prediction increased a patient's nonresponse/response likelihoods by +37.1%/+32.5%,</s><s>summing up to a gain in prognostic accuracy of +69.6%.</s><s>In contrast, the supplementary prediction analysis using global and total-intracranial volumes provided a crossvalidated BAC of 66.7% (Sensitivity: 66.7%, Specificity: 66.7%; supplementary table 3).</s><s>The lowest prediction performance (BAC: 60.1%, Sensitivity: 58.3%, Specificity: 61.9%) was observed when modulated GM maps were used instead of GMD maps.</s></p><p><s>The neuroanatomical pattern predicting subsequent nonresponse to active rTMS particularly involved relative GMD reductions in the (1) dorsomedial and ventromedial prefrontal, frontopolar and cingulate cortices, (2) the insular, opercular, temporopolar and medial temporal cortices, and (3) the cerebellum (figure <ref type="figure" target="#fig_1">1</ref>).</s><s>Increased baseline GMD predicting nonresponse was observed in the left-hemispheric somatosensory and parietal cortices with extensions to the lateral temporal and premotor structures, as well as in the thalamic nuclei, bilaterally.</s><s>This pattern of relative GMD reductions and increments was much more extended than the differences detected by the univariate GMD analysis (supplementary figure <ref type="figure">6</ref>).</s><s>There, we found only cerebellar and circumscribed medial prefrontal and frontopolar GMD reductions to be associated with subsequent nonresponse to rTMS.</s><s>Permutation analysis showed that the BAC generated by the machine learning-based pattern was significant at P &lt; .001.</s><s>Furthermore, this pattern specifically separated nonresponders from responders in the active, but not in the sham treatment group: the trained active rTMS predictor's BAC measured 57.5% (56.0%, 59.1%; table 2) in the latter patients.</s><s>Moreover, our machine learning pipeline produced an accurate predictor for the PANSS-NS endpoint, but not for PANSS-PS (BAC = 35.9%;</s><s>table 2).</s><s>Finally, the active rTMS predictor was not significantly moderated by sociodemographic and clinical variables, antipsychotic treatment intensity (chlorpromazine equivalents) at baseline and over the treatment period, type of psychopharmacological treatment (clozapine, antidepressants, mood stabilizers), as well as the scalp-to-cortex distances of Brodmann Areas 9 and 46, or the left resting motor threshold (RMT) (table <ref type="table" target="#tab_4">3</ref>).</s></p><p><s>When validating the active rTMS model's LSO generalizability, we measured an overall BAC (sensitivity, specificity) of 71.1% (70.8%, 71.4%; P &lt; .001;</s><s>table <ref type="table" target="#tab_2">2</ref>).</s><s>The lowest/ highest BAC of 64.1%/100% (each P &lt; .05)</s><s>was observed when the 22/6 patients from Regensburg/Duesseldorf were used for LSO validation (49%/13.3% of the active rTMS sample).</s><s>These performances did not differ from the BACs obtained in the 1000 random permutations of the patients' site membership (all P &gt; .35,</s><s>table 2) indicating that the BAC drop between pooled and LSO analysis was due to smaller training samples and not residual site effects.</s><s>Finally, in contrast to the active rTMS outcome classifier, the predictive model trained on the sham rTMS sample produced a BAC of 51.3% (48.0%, 54.6%), which was nonsignificant and non-generalizable (table <ref type="table" target="#tab_2">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Neuroanatomical Nonresponse Likelihoods Relating to Outcome Trajectories</head><p><s>The neuroanatomical response probabilities obtained from the active rTMS predictor explained 34% of the variance in the PANSS-NS changes measured Duesseldorf (SD) 39 2.0 (0.9) 2.0 (1.0) 0.9 (0.9) 0.9 (0.9) 75.0 the classifiers' capacity to correctly identify patients with nonresponse to the respective treatment as such.</s><s>For both the active and sham rTMS predictor 2 types of validation analyses were carried out: Pooled Repeated Nested Cross-Validation (P-CV), and Leave-Site-Out Repeated Nested Validation (LSO-CV), which iteratively trained the respective predictor 2 of the 3 sites and then applied the trained predictor to the held-back site.</s><s>In the active rTMS condition 3 further analyses were conducted: (1) analysis of performance non-inferiority of LSO-CV vs P-CV experiments comparing the effects of reduced training sample size vs site/scanner effects on classification performance, (2)   sham rTMS validation analysis: the active rTMS predictor trained in the P-CV experiment was applied to the sham-treated patients to assess the specificity of the predictive models for the active treatment, and (3) a P-CV analysis of the single-patient predictability of a PANSS-PS outcome criterion.</s></p><formula xml:id="formula_2">(</formula><p><s>a P value obtained from permutation analysis of P-CV/ LSO-CV predictors trained on respective original label distributions vs 1000 respective predictors trained on random label permutations.</s></p><p><s>b P value obtained from permutation analysis of LSO-CV predictors trained on respective original site label distributions vs 1000 respective predictors trained on random permutations of the patients' site labels.</s><s>*P &lt; 0.05.</s></p><p><s>between T0 and T1 (ρ = 0.583, P &lt; .0001;</s><s>figure <ref type="figure" target="#fig_3">3A</ref>).</s><s>Furthermore, the mixed-model analysis applied to the absolute PANSS-NS scores of this patient group showed a significant main effect of predicted outcome group on the PANSS-NS trajectories (F = 13.6,</s><s>P &lt; .001;</s><s>figure <ref type="figure" target="#fig_3">3B</ref>).</s><s>The trajectories analyzed in the mixed model did not include the day 21 (T1) target of the neuroanatomical classifier nor its closest day 28 (T2) time point, but spanned T0, T3 and T4, which indicates that the response vs nonresponse stratification was stable up to 2 months after the completion of treatment.</s><s>Additional mixed-model analyses showed that patients stratified into PANSS-NS responders vs nonresponders also differed significantly in their GAF trajectories (supplementary figure <ref type="figure">4</ref>).</s><s>Similar stratification effects were not observed for the respective PANSS-PS or MADRS courses (supplementary material).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>This is to our knowledge the first study reporting the successful application of MRI-based machine learning to the prediction of individual responses to the rTMS treatment of neuropsychiatric illness.</s><s>The predictive Importantly, we did not find any sociodemographic, clinical, or psychopharmacological treatment parameters to confound the active rTMS outcome classifier's stratification effects.</s><s>These effects were not limited to a short-term separation between negative symptom responders vs responders but extended for 3 months into the post-treatment naturalistic follow-up period.</s><s>We also found that the PANSS-NS stratification effects generalized to the patients' global functioning trajectories, suggesting that relative prefronto-temporo-limbic GMD reductions prior to treatment start moderate both a subsequent improvement of negative symptoms and functioning induced by rTMS to the left DLPFC.</s><s>This neuroanatomical baseline variance in patients with schizophrenia may represent an important, so far unknown biological factor driving the equivocal efficacy reported by previous rTMS studies in the field. <ref type="bibr" target="#b4">5</ref></s><s>ur validation analyses showed that the active rTMS outcome predictor was not only accurate but also therapeutically specific because the model did not distinguish globally between good vs poor symptom courses, as shown by our negative findings in the patients' psychotic and depressive symptoms domains.</s><s>The low prediction performance of the active rTMS predictor in sham-treated patients further corroborated the detected structural brain pattern's high predictive specificity for verum effects on the negative symptom trajectories.</s><s>Moreover, the contrast between the accurate PANSS-NS and the weak PANSS-PS outcome classifier supports the predictive specificity of the detected neuroanatomical marker for the left-hemispheric DLPFC stimulation and its downstream neural system-level effects.</s><s>This interventional specificity agrees with 2 meta-analyses suggesting a superiority of (1) the left DLPFC as stimulation target for negative symptoms compared to other locations, <ref type="bibr" target="#b42">42</ref> and (2) the left temporo-parietal junction over other stimulation targets for the rTMS treatment of psychotic symptoms, ie, auditory verbal hallucinations. <ref type="bibr" target="#b43">43</ref></s><s>The former meta-analysis extracted further potential predictors of DLPFC-rTMS efficacy on negative symptoms: a baseline PANSS-NS ≥ 20, RMS stimulation intensity of 110%, rTMS frequency of 10 Hz and treatment duration of ≥3 weeks, as well as a duration of illness &lt;8 years.</s><s>Despite the implementation of all these recommendations in RESIS, <ref type="bibr" target="#b5">6</ref> we did not find any superiority of active vs sham treatment on clinical and cognitive outcomes. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b8">9</ref></s><s>Our current findings suggest that these previous negative results may have been mediated by a neuroanatomically determined response variability, which obscured active treatment efficacy in the randomized clinical trial design.</s><s>Hence, prospective clinical trials are needed to test whether matching of suitable patients to rTMS can enhance treatment outcomes based on pre-treatment MRI-based patient stratification.</s></p><p><s>A recent study investigated the predictive value of the neuroanatomical properties of the left temporal lobe on rTMS efficacy in treating refractory auditory verbal hallucinations.</s><s>The authors reported that the Scalp-to-Cortex Distance (SCD) and local GMD of this structure were predictive of treatment response. <ref type="bibr" target="#b14">15</ref></s><s>In contrast, we did not find any significant effects of the SCD over Brodmann Areas 9 and 46 on active rTMS treatment outcomes or on the structural adaptions of the left hippocampal-precuneal networks in our present or previous work (table <ref type="table" target="#tab_4">3</ref>).</s><s>In turn, we explored whether changes in brain structure following active rTMS previously reported for a subset of 33 RESIS patients 20 could be predicted by our neuroanatomical model (supplementary results).</s><s>In this subsample, we observed a significant association (F = 4.09, P = .015)</s><s>between the patients' PANSS-NS outcome probabilities generated by our active rTMS predictor (figure <ref type="figure" target="#fig_2">2</ref>) and subsequent left hippocampal volume increases.</s><s>This finding suggests that the model's neuroanatomical decision rule, which involved reduced prefronto-limbic and cerebellar GMD as well as increased premotor-thalamic GMD at baseline, not only successfully stratified different PANSS-NS courses, but also predicted longitudinal brain changes in the limbic system induced by active rTMS applied to the left DLPFC.</s><s>Still, the relationship between the predictor's mesoscopic <ref type="bibr" target="#b32">32</ref> structural brain pattern and the underlying mechanistic surrogate remains unclear.</s><s>Recent evidence suggested that the T1-weighted images analyzed here (and by the majority of structural neuroimaging studies) are significantly influenced by the microstructural properties of the brain tissue such as myelination, iron and water content. <ref type="bibr" target="#b44">44</ref></s><s>Further imaging studies using parallel quantitative MRI protocols may disentangle the contributions of these histopathological factors and thus shed light on the structural mechanisms determining a patient's capacity to respond to rTMS.</s></p><p><s>6]<ref type="bibr" target="#b47">[47]</ref> Further system-level overlaps can be traced when comparing our pattern with a recent study assessing possible links between baseline resting-state fMRI connectivity, clinical phenotypes of depression and subsequent response to rTMS in a large sample of 1188 patients, of whom 154 were treated with rTMS. <ref type="bibr" target="#b23">24</ref></s><s>This study detected 4 distinct depression biotypes that differentially predicted rTMS efficacy: Biotype 1 characterized by anhedonia, psychomotor retardation, and orbitofrontal as well as limbic hypoconnectivity showed the highest response likelihood to rTMS (82.5%) in contrast to biotype 4 (29.6%) which was characterized by hyperconnectivity in fronto-striatal networks and higher anxiety scores.</s><s>Evidence for an impaired anticorrelated coupling between the DLPFCbased Central Executive Network (CEN) and the medial prefrontal, frontopolar and medial parietal regions of the Default Mode Network (DMN) has been provided by studies investigating the neural correlates of rTMS efficacy in depression. <ref type="bibr" target="#b48">48,</ref><ref type="bibr" target="#b49">49</ref></s><s>In fact, high-frequency rTMS may attenuate abnormally elevated within-DMN connectivity <ref type="bibr" target="#b50">50</ref> and restore the anticorrelated activation patterns of DMN and CEN. <ref type="bibr" target="#b51">51</ref></s><s>Recently, these findings have been extended to schizophrenia showing DMN suppression deficits in cognitively impaired vs non-impaired patients with first-episode psychosis <ref type="bibr" target="#b52">52</ref> as well as altered connectivity patterns between different DMN subnetworks and the CEN. <ref type="bibr" target="#b53">53</ref></s><s>Latter work also provided evidence that these alterations are associated with the severity of negative symptoms in schizophrenia and can be used to separate patients from healthy controls with &gt;75% accuracy. <ref type="bibr" target="#b53">53</ref></s><s>If we relate the pattern of DMN-related GMD reductions and motor-thalamic increments observed in our study to this previous evidence, we may speculate that rTMS responders have a more functionally hyperactive DMN at baseline and thus increased GMD in these regions compared to nonresponders who show extended structural deficits in DMN-related hubs, reducing their capacity for adaptive brain responses following rTMS. <ref type="bibr" target="#b19">20</ref></s><s>n the context of these hypotheses, the heterogeneity of neuroanatomical and clinical phenotypes underlying schizophrenia, <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23</ref> and their overlaps with early-onset depression, <ref type="bibr" target="#b33">33</ref> point to complex biotypes conferring differential response likelihoods to noninvasive brain stimulation techniques through still unknown interactions between molecular, neuroanatomical, neurofunctional and neurophysiological factors.</s><s>The present results linking baseline neuroanatomical variation in schizophrenia with adaptive behavioral and structural brain changes following rTMS suggest the value of future in-depth mechanistic investigations analyzing large-scale patient samples using combinations of multi-modal MRI, brain stimulation and multivariate analysis techniques.</s></p><p><s>The predictive performance of the active rTMS predictor reported here is comparable to those of a recent noncontrolled open-label neuroimaging study predicting the outcome of depressive and schizophrenic patients following ECT. <ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26</ref></s><s>However, to the best of our knowledge, our study is the first to demonstrate the feasibility of a reliable MRI-based prediction of rTMS-treatment outcomes based on the superior evidence levels provided by a stateof-the-art controlled RCT design.</s><s>This design enabled us to benchmark the leave-site-out generalizability, the interventional (active vs sham) and outcome domain specificity, as well as the temporal stability of the model's predictions.</s><s>The results obtained in these validation analyses suggest that the high response variability to noninvasive brain stimulation observed in many trials using rTMS for the treatment of depression <ref type="bibr" target="#b54">54,</ref><ref type="bibr" target="#b55">55</ref> or schizophrenia 5 may be successfully mapped to pre-treatment structural brain patterns.</s><s>So far, variability rates up to 50% in rTMS protocols have hampered the overall clinical efficacy of rTMS in research and clinical care, challenging the prediction of rTMS in any individual patient. <ref type="bibr" target="#b56">56</ref></s><s>Our findings suggest that MRI-based machine learning derived from a careful RCT design may foster a better understanding of and the ability to predict how different disease-related brain phenotypes contribute to the individual patient's capacity to respond to brain stimulation.</s><s>Further validation of the identified predictive pattern in larger, but currently unavailable external patient databases and future biomarker-stratified clinical trials <ref type="bibr" target="#b57">57</ref> could be important next steps to reduce the response variability, increase the clinical efficacy and propel the availability of rTMS as a valid treatment option for patients with predominant negative schizophrenia.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Model significance was defined at α = .</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Reliability of the baseline gray matter density pattern predicting subsequent response vs nonresponse to active repetitive transcranial magnetic stimulation (rTMS).</s><s>The reliability of the gray matter density (GMD) pattern elements was measured in terms of a Cross-Validation Ratio (CVR) map [CVR = mean(w) / standard error(w)], where w are the weight vectors of the 5111 Support Vector Machine (SVM) models generated in the study's repeated nested cross-validation setup].</s><s>The CVR map was thresholded at a CVR of ±3, corresponding to an alpha level of .01</s><s>reliable areas of GMD reduction in non-responders (NON-RESP) vs responders (RESP) are shaded in red colours, whereas areas of GMD increments are painted in green.</s><s>The open-source 3D rendering software MRIcroGL (C.</s><s>Rohrden) available at https://www.nitrc.org/projects/mricrogl/</s><s>was used to overlay the CVR map on the MNI single-subject template.</s></p></div></figDesc><graphic coords="4,147.86,63.50,288.00,444.29" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Sorted neuroanatomical nonresponse likelihoods of patients treated with active repetitive transcranial magnetic stimulation (rTMS) (A1).</s><s>For each patient in study population the active rTMS outcome predictor generated ensemble-based out-of-training probabilities of belonging to the nonresponse group (y axis).</s><s>The figure shows these likelihoods sorted in ascending order, with redcolored subjects indicating misclassifications.</s><s>Using these outcome predictions, a Receiver-Operating Characteristic (ROC) analysis was conducted (A2).</s><s>Based on the patients identified as support vectors by the Support Vector Machine (SVM) algorithm, voxel-level mean and standard deviation maps were computed and used to standardize patients in the active rTMS group.</s><s>The standardized maps were separately averaged for the 2 prediction groups to illustrate the quantitative baseline gray matter density (GMD) differences between patients with predicted nonresponses (top) vs responses (bottom) to active rTMS.</s><s>The bottom panel of the figure shows the sorted outcome probabilities and misclassification (circles) for each of the 3 RESIS sites (B1) as well as the respective ROCs and Areas-underthe-Curve (AUC; B2).</s></p></div></figDesc><graphic coords="5,121.44,63.50,361.13,454.28" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. (A) Correlation analyses between patients' neuroanatomical likelihood of nonresponse to active (top) and sham (bottom) TMS and PANSS-NS absolute score changes measured between T0 and T1.</s><s>(B) Descriptive absolute PANSS-NS trajectory graphs of patients with predicted nonresponse (red) vs response (green) to active (top) vs sham (bottom) repetitive transcranial magnetic stimulation (rTMS) spanning from baseline to day 105 follow-up examinations.</s><s>Here, the T1 timepoint (day 21) was included in the figure for visualization purposes.</s></p></div></figDesc><graphic coords="6,111.41,63.50,360.90,272.70" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>table 1</head><label>1</label><figDesc></figDesc><table /><note><p><s>). Treatment responses observed in our MRI sample also agree with the ITT analysis, with both treatment groups improving similarly over time (PANSS: all F ≥ 10.51, all P ≤ .002;</s><s>MADRS: F (1,89) = 17.27,</s><s>P &lt; .001;</s><s>GAF: F (1,83) = 16.24,</s><s>P &lt; .001;</s><s>supplementary table 2).</s><s>Distributions of PANSS-NS responders and nonresponders were equal across rTMS conditions (active vs sham rTMS responders/nonresponders: 21/24 vs 22/25; χ (1) 2 0 001 &lt; .</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Sociodemographic and Clinical Differences at Baseline Between Patients Treated With Active vs Sham rTMS</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Active vs Sham</cell><cell></cell></row><row><cell></cell><cell>Active rTMS</cell><cell></cell><cell>Sham rTMS</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>(n = 45)</cell><cell></cell><cell>(n = 47)</cell><cell></cell><cell>χ 2</cell><cell>df</cell><cell>P</cell></row><row><cell>Sociodemographic variables</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Gender (male: female)</cell><cell>39:6</cell><cell></cell><cell>37:10</cell><cell></cell><cell>1.010</cell><cell>1</cell><cell>.315 a</cell></row><row><cell>Site (Goettingen: Regensburg: Duesseldorf)</cell><cell>17:22:6</cell><cell></cell><cell>17:22:8</cell><cell></cell><cell>0.242</cell><cell>2</cell><cell>.886 a</cell></row><row><cell>Hand preference (right: not right)</cell><cell>39:5</cell><cell></cell><cell>39:6</cell><cell></cell><cell>0.080</cell><cell>1</cell><cell>.778 a</cell></row><row><cell></cell><cell>Mean</cell><cell>SD</cell><cell>Mean</cell><cell>SD</cell><cell>t</cell><cell></cell><cell></cell></row><row><cell>Age (y)</cell><cell>34.00</cell><cell>9.93</cell><cell>35.64</cell><cell>9.37</cell><cell>0.814</cell><cell>90</cell><cell>.418 b</cell></row><row><cell>Education (y)</cell><cell>11.43</cell><cell>1.91</cell><cell>11.34</cell><cell>2.13</cell><cell>0.215</cell><cell>89</cell><cell>.830 b</cell></row><row><cell>rTMS functional and anatomical parameters</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Left Resting Motor Threshold (RMT)</cell><cell>46.72</cell><cell>10.31</cell><cell>47.95</cell><cell>11.78</cell><cell>0.519</cell><cell>85</cell><cell>.605 b</cell></row><row><cell>Scalp-to-cortex distance BA 9 (mm)</cell><cell>16.27</cell><cell>2.16</cell><cell>16.68</cell><cell>1.92</cell><cell>−0.951</cell><cell>90</cell><cell>.344 b</cell></row><row><cell>Scalp-to-cortex distance BA 46 (mm)</cell><cell>16.28</cell><cell>2.43</cell><cell>16.90</cell><cell>2.50</cell><cell>−1.211</cell><cell>90</cell><cell>.299 b</cell></row><row><cell>Severity of illness and treatment</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>PANSS negative symptoms</cell><cell>26.31</cell><cell>4.45</cell><cell>25.91</cell><cell>4.42</cell><cell>0.428</cell><cell>90</cell><cell>.669 b</cell></row><row><cell>PANSS positive symptoms</cell><cell>14.41</cell><cell>4.33</cell><cell>12.36</cell><cell>3.15</cell><cell>2.565</cell><cell>87</cell><cell>.012* b</cell></row><row><cell>PANSS general symptoms</cell><cell>42.36</cell><cell>9.46</cell><cell>38.73</cell><cell>9.92</cell><cell>1.766</cell><cell>87</cell><cell>.081 b</cell></row><row><cell>PANSS total</cell><cell>83.23</cell><cell>14.23</cell><cell>77.27</cell><cell>14.76</cell><cell>1.939</cell><cell>87</cell><cell>.056 b</cell></row><row><cell>Global Assessment of Functioning</cell><cell>52.07</cell><cell>12.27</cell><cell>52.37</cell><cell>11.77</cell><cell>0.115</cell><cell>83</cell><cell>.908 b</cell></row><row><cell>Antipsychotic Dose (CPZ mg)</cell><cell>598.60</cell><cell>451.14</cell><cell>596.60</cell><cell>494.49</cell><cell>0.020</cell><cell>86</cell><cell>.984 b</cell></row><row><cell>Depression severity</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Montgomery-Åsberg Depression Rating Scale</cell><cell>14.48</cell><cell>5.48</cell><cell>13.83</cell><cell>5.59</cell><cell>0.557</cell><cell>89</cell><cell>.579 b</cell></row><row><cell>(MADRS)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>Note: PANSS, Positive and Negative Syndrome Scale; CPZ: Chlorpromazine equivalents, BA: Brodmann Area; rTMS, repetitive transcranial magnetic stimulation.</s><s>Sociodemographic and Clinical Differences Were Assessed Using Independent t tests and Chi-square tests in SPSS 23. a P value obtained from Chi-square test on independence.</s><s>b P value obtained from independent t test.</s><s>*P &lt; 0.05.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Validated Predictive Performances of Active and Sham rTMS Response Classifiers</s></p></div></figDesc><table><row><cell>Machine Learning Analyses N tr TP TN FP FN Sens Spec BAC PPV NPV PSI LR+ DOR P</cell><cell>Active rTMS: PANSS-NS outcome predictor</cell><cell>Pooled repeated nested cross-validation (P-CV) 45 19 19 2 5 79.2 90.2 84.8 90.5 79.2 69.6 8.3 69.1 &lt;.001* a</cell><cell>Leave-site-out repeated nested cross-validation (LSO-CV)</cell><cell>Full sample 45 16 16 5 8 70.8 71.4 71.1 73.9 68.2 42.1 2.50 6.1 &lt;.001* a</cell><cell>Goettingen left-out 28 6 6 3 2 75.0 66.7 70.8 66.7 75.0 41.7 2.25 5.1 .029* a</cell><cell>Regensburg left-out 23 8 6 3 5 61.5 66.7 64.1 72.7 54.5 27.3 1.85 3.4 .042* a</cell><cell>Duesseldorf left-out 39 3 3 0 0 100 100 100 100 100 100 --.007* a</cell><cell>Non-inferiority analysis of LSO-CV vs P-CV based on 1000 permutations of the site labels: Mean (SD) performance of permuted LSO predictors</cell><cell>Full sample (SD) 45 17.0 (2.5) 13.6 (2.6) 7.4 (2.6) 7.3 (2.5) 70.8 66.7 67.9 69.6 66.7 37.5 2.00 4.0 .725 b</cell><cell>(10.3) (12.4) (7.0) (7.5) (8.1) (14.2)</cell><cell>Goettingen (SD) 28 6.0 (1.3) 5.1 (1.5) 2.9 (2.2) 2.6 (1.9) 72.7 66.7 70.1 72.7 66.7 41.7 2.18 4.8 .582 b</cell><cell>(16.9) (21.4) (10.4) (16.8) (17.2) (20.8)</cell><cell>Regensburg (SD) 23 8.0 (2.0) 6.5 (1.8) 3.7 (2.6) 3.8 (2.7) 72.1 66.7 68.2 71.4 66.7 39.3 2.16 4.8 .359 b</cell><cell>(19.1) (20.8) (9.0) (15.3) (14.8) (18.1)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head></head><label></label><figDesc><div><p><s>Positive/negative predictions refer to treatment nonresponse/response after 3 weeks of active or sham rTMS.</s><s>Hence sensitivity measures</s></p></div></figDesc><table><row><cell>75.0 80.0 75.0 66.7 50.0 4.00 16.0 .979 b</cell><cell>23.3) (26.9) (18.1) (26.3) (27.4) (35.1)</cell><cell>56.0 59.1 57.5 60.9 54.2 15.0 1.37 1.87 -</cell><cell></cell><cell></cell><cell>20.0 51.7 35.9 17.6 55.6 -26.8 0.41 0.17 -</cell><cell></cell><cell>48.0 54.6 51.3 54.6 48.0 2.55 1.06 1.12 .441</cell><cell></cell><cell>48.0 36.4 42.2 46.2 38.1 -15.8 0.75 0.57 .913</cell><cell>77.8 0.0 38.9 46.7 0.0 -53.3 0.78 0.60 .895</cell><cell>44.4 30.8 37.6 44.4 30.8 -24.8 0.56 0.31 .955</cell><cell>33.3 80.0 56.7 50.0 66.7 16.7 1.67 2.78 .299</cell><cell>Spec Specificity, TN true negatives, TP true positives; rTMS, repetitive</cell></row><row><cell></cell><cell></cell><cell>9 11</cell><cell></cell><cell></cell><cell>14 12</cell><cell></cell><cell>10 13</cell><cell></cell><cell>14 13</cell><cell>8 2</cell><cell>5 9</cell><cell>1 2</cell><cell>Sens Sensitivity,</cell></row><row><cell></cell><cell></cell><cell>13</cell><cell></cell><cell></cell><cell>15</cell><cell></cell><cell>12</cell><cell></cell><cell>8</cell><cell>0</cell><cell>4</cell><cell>4</cell></row><row><cell></cell><cell></cell><cell>45 14</cell><cell></cell><cell></cell><cell>44 3</cell><cell></cell><cell>47 12</cell><cell></cell><cell>47 12</cell><cell>30 7</cell><cell>25 4</cell><cell>39 1</cell></row><row><cell></cell><cell></cell><cell>Validation of the active rTMS predictor in sham-treated</cell><cell>patients (active rTMS predictor trained in P-CV)</cell><cell>Active rTMS: PANSS-PS outcome predictor</cell><cell>Pooled repeated nested cross-validation</cell><cell>Sham rTMS: PANSS-NS outcome predictor</cell><cell>Pooled repeated nested cross-validation</cell><cell>Leave-site-out repeated cross-validation</cell><cell>Full sample</cell><cell>Goettingen left-out</cell><cell>Regensburg left-out</cell><cell>Duesseldorf left-out</cell><cell>transcranial magnetic stimulation.</cell></row></table><note><p><s>Note: BAC, balanced accuracy; DOR, Diagnostic Odds Ratio; FN, false negatives; FP, false positives; LR+, Positive Likelihood ratio; NPV, Negative Predictive Value; PPV, Positive Predictive Value; PSI, Prognostic Summary Index (PSI = PPV + NPV − 100),</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Sociodemographic and Clinical Differences at Baseline Between Patients Predicted With a Day 21-Response vs Nonresponse to Active rTMS PANSS, Positive and Negative Syndrome Scale; CPZ, Chlorpromazine Equivalents, BA, Brodmann Area; rTMS, repetitive transcranial magnetic stimulation.</s><s>Sociodemographic, Clinical and Psychopharmacological Treatment Differences Were Assessed Using Independent t and Chi-square tests in SPSS 23. model provided accurate outcome estimates in 8.4 of 10 patients and the employed methods facilitated robust generalizability to new study sites despite the significantly lower training sample sizes in the leave-site-out analysis.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="3">Nonresponse vs Response</cell></row><row><cell></cell><cell cols="2">Active rTMS (Predicted</cell><cell cols="2">Active rTMS (Predicted</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell cols="2">Nonresponse) (n = 21)</cell><cell cols="2">Response) (n = 24)</cell><cell>χ 2</cell><cell>df</cell><cell>P</cell></row><row><cell>Sociodemographic variables</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Gender (male: female)</cell><cell>19:2</cell><cell></cell><cell>20:4</cell><cell></cell><cell>0.495</cell><cell>1</cell><cell>.482</cell></row><row><cell>Site (Goettingen: Regensburg:</cell><cell>7:11:3</cell><cell></cell><cell>10:11:3</cell><cell></cell><cell>0.331</cell><cell>2</cell><cell>.848</cell></row><row><cell>Düsseldorf)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Hand preference (right:</cell><cell>18:2</cell><cell></cell><cell>21:3</cell><cell></cell><cell>0.068</cell><cell>1</cell><cell>.795</cell></row><row><cell>non-right)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Mean</cell><cell>SD</cell><cell>Mean</cell><cell>SD</cell><cell>t</cell><cell></cell><cell></cell></row><row><cell>Age (y)</cell><cell>35.81</cell><cell>11.72</cell><cell>32.42</cell><cell>7.97</cell><cell>1.148</cell><cell>43</cell><cell>.257</cell></row><row><cell>Education (y)</cell><cell>11.45</cell><cell>1.99</cell><cell>11.42</cell><cell>1.87</cell><cell>0.057</cell><cell>42</cell><cell>.955</cell></row><row><cell cols="2">rTMS functional and anatomical parameters</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Left Resting Motor Threshold</cell><cell>48.86</cell><cell>9.79</cell><cell>44.68</cell><cell>10.60</cell><cell>1.340</cell><cell>41</cell><cell>.188</cell></row><row><cell>(RMT)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Scalp-to-cortex distance BA</cell><cell>16.13</cell><cell>1.90</cell><cell>16.40</cell><cell>2.40</cell><cell>−0.416</cell><cell>43</cell><cell>.679</cell></row><row><cell>9 (mm)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Scalp-to-cortex distance BA</cell><cell>15.76</cell><cell>2.12</cell><cell>16.74</cell><cell>2.63</cell><cell>−1.359</cell><cell>43</cell><cell>.181</cell></row><row><cell>46 (mm)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Illness severity and functioning at baseline</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>PANSS negative symptoms</cell><cell>26.52</cell><cell>4.94</cell><cell>26.13</cell><cell>4.10</cell><cell>−0.297</cell><cell>43</cell><cell>.768</cell></row><row><cell>PANSS positive symptoms</cell><cell>13.95</cell><cell>4.15</cell><cell>14.83</cell><cell>4.53</cell><cell>−0.665</cell><cell>42</cell><cell>.510</cell></row><row><cell>PANSS general symptoms</cell><cell>43.24</cell><cell>10.22</cell><cell>41.57</cell><cell>8.86</cell><cell>0.582</cell><cell>42</cell><cell>.564</cell></row><row><cell>PANSS total</cell><cell>83.71</cell><cell>15.55</cell><cell>82.78</cell><cell>13.24</cell><cell>0.214</cell><cell>41</cell><cell>.831</cell></row><row><cell>Global assessment of</cell><cell>49.40</cell><cell>13.93</cell><cell>54.50</cell><cell>10.30</cell><cell>−1.359</cell><cell>40</cell><cell>.182</cell></row><row><cell>functioning</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Psychopharmacological treatment</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Antipsychotic dose (CPZ mg)</cell><cell>629.83</cell><cell>398.99</cell><cell>574.16</cell><cell>495.60</cell><cell>0.388</cell><cell>39</cell><cell>.700</cell></row><row><cell>at T0</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Cumulative antipsychotic dose</cell><cell>13226.39</cell><cell>8378.73</cell><cell>12112.25</cell><cell>10426.69</cell><cell>0.369</cell><cell>39</cell><cell>.714</cell></row><row><cell>(CPZ mg) between T0 and T1</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>χ 2</cell><cell>df</cell><cell>P</cell></row><row><cell>Treated with clozapine (yes:no)</cell><cell>2:19</cell><cell></cell><cell>6:18</cell><cell></cell><cell>1.835</cell><cell>1</cell><cell>.176</cell></row><row><cell>Treated with antidepressants</cell><cell>10:11</cell><cell></cell><cell>7:17</cell><cell></cell><cell>1.622</cell><cell>1</cell><cell>.233</cell></row><row><cell>(yes:no)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Treated with mood stabilizers</cell><cell>3:18</cell><cell></cell><cell>1:23</cell><cell></cell><cell>1.416</cell><cell>1</cell><cell>.234</cell></row><row><cell>(yes:no)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Depression severity</cell><cell>Mean</cell><cell>SD</cell><cell>Mean</cell><cell>SD</cell><cell>t</cell><cell></cell><cell></cell></row><row><cell>Montgomery-Åsberg</cell><cell>14.95</cell><cell>5.88</cell><cell>14.08</cell><cell>5.22</cell><cell>0.518</cell><cell>42</cell><cell>.607</cell></row><row><cell>Depression Scale (MADRS)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Note:</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>N.K. has received paid speakership from Otsuka at 3 occasions.</s><s>T.W. has received paid speakerships from Alpine Biomed, AstraZeneca, Bristol Myers Squibb, Eli Lilly, I3G, Janssen Cilag, Novartis, Lundbeck, Roche, Sanofi-Aventis, Otsuka and Pfizer, and has accepted travel or hospitality not related to a speaking engagement from AstraZeneca, Bristol-Myers-Squibb, Eli Lilly, Janssen Cilag, and Sanofi-Synthelabo; and has received restricted research grants from AstraZeneca, Cerbomed, I3G and AOK (health insurance company).</s><s>B.L. received honoraria and speakers' fees from ANM, Astra Zeneca, Autifony, Lundbeck, Merz, Magventure, Novartis, Pfizer and Servier, research funding from the Tinnitus Research Initiative, the German Research Foundation, the German Bundesministerium für Bildung und Forschung, the American Tinnitus Association, Astra Zeneca and Cerbomed, funding for equipment from Magventure and Deymed and travel and accommodation payments from Lilly, Lundbeck, Servier and Pfizer.</s><s>J.C. was a member of an advisory board of Roche, accepted travel or hospitality not related to a speaking engagement from</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p><s>Supplementary data is available at Schizophrenia Bulletin online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>The Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia (RESIS) trial was supported by the Deutsche Forschungsgemeinschaft Grant No. FA-210/1.</s><s>The funding source was not involved in the study design, the collection and analysis of the data, or the writing of the manuscript.</s><s><ref type="figure">H</ref>. is an unpaid member of the Advisory Board of In Silico Biosciences, and a paid consultant to Otsuka/Lundbeck, Roche, Novartis, Eli Lilly, MDH Consulting, and the Canadian Agency on Drugs and Technology in Health.</s><s>P.F. was honorary speaker for Janssen-Cilag, Astra-Zeneca, Eli Lilly, Bristol Myers-Squibb, Lundbeck, Pfizer, Bayer Vital, SmithKline Beecham, Wyeth, and Essex.</s><s>During the last 5 years, but not presently, he was a member of the advisory boards of Janssen-Cilag, AstraZeneca, Eli Lilly, and Lundbeck.</s><s>A.H. has been invited to scientific meetings by Lundbeck, Janssen-Cilag, and Pfizer, and he received a paid speakership from Desitin, Otsuka and Lundbeck.</s><s>He was member of an advisory board of Roche.</s><s>B.G., M.L., P.E., E.F., F.M., G.W., C.O., P.E.V., M.R., R.A., D.D., F.G., P.D., B.M., P.M.K., T.B.P., and T.S-A.</s><s>had no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Long-term effects of repetitive transcranial magnetic stimulation on markers for neuroplasticity: differential outcomes in anesthetized and awake animals</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gersner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kravetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Feil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zangen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="7521" to="7526" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">rTMS of the prefrontal cortex has analgesic effects on neuropathic pain in subjects with spinal cord injury</title>
		<author>
			<persName><forename type="first">R</forename><surname>Nardone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Höller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Langthaler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Spinal Cord</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="20" to="25" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Transcranial magnetic stimulation (TMS) in stroke: Ready for clinical practice?</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Stinear</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Neurosci</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="10" to="14" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Blumberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Maller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Thomson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychiatry Neurosci</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="E58" to="E66" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Repetitive noninvasive brain stimulation to modulate cognitive functions in schizophrenia: a systematic review of primary and secondary outcomes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Strube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Palm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wobrock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Schizophr Bull</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S95" to="S109" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Left prefrontal highfrequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Wobrock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Guse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cordes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="979" to="988" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Delayed effect of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia: findings from a randomized controlled trial</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">L</forename><surname>Lyu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">D</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Hung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychiatry Res</title>
		<imprint>
			<biblScope unit="volume">240</biblScope>
			<biblScope unit="page" from="333" to="335" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mogg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Purvis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Eranti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Schizophr Res</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="221" to="228" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Cognitive effects of highfrequency rTMS in schizophrenia patients with predominant negative symptoms: results from a multicenter randomized sham-controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Guse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cordes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Schizophr Bull</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="608" to="618" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: results of a multicenter double-blind randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Dlabac-De Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Van Es</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychol Med</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1263" to="1275" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Transcranial magnetic stimulation and auditory hallucinations in schizophrenia</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Hoffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">N</forename><surname>Boutros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Berman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Krystal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Charney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">355</biblScope>
			<biblScope unit="page" from="1073" to="1075" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Functional connectivity of the temporo-parietal region in schizophrenia: effects of rTMS treatment of auditory hallucinations</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vercammen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Knegtering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Liemburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Den Boer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aleman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychiatr Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="725" to="731" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A sham-controlled trial of left and right temporal rTMS for the treatment of auditory hallucinations</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Loo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sainsbury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hadzi-Pavlovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Sachdev</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychol Med</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="541" to="546" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Neurobiological predictors of response to dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation in depression: a systematic review</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Silverstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Noda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Barr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Depress Anxiety</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="871" to="891" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Cortical anatomical variations and efficacy of rtms in the treatment of auditory hallucinations</title>
		<author>
			<persName><forename type="first">C</forename><surname>Nathou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dollfus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Etard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Stimul</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1162" to="1167" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The role of interneuron networks in driving human motor cortical plasticity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Murase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Balaratnam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Rothwell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cereb Cortex</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1593" to="1605" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Inter-individual variability in cortical excitability and motor network connectivity following multiple blocks of rTMS</title>
		<author>
			<persName><forename type="first">C</forename><surname>Nettekoven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Volz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leimbach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroimage</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="209" to="218" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression</title>
		<author>
			<persName><forename type="first">I</forename><surname>Aguirre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Carretero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Ibarra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Affect Disord</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="466" to="469" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Kraepelin revisited: schizophrenia from degeneration to failed regeneration</title>
		<author>
			<persName><forename type="first">P</forename><surname>Falkai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rossner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Schulze</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="671" to="676" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wobrock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Guse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="857" to="864" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m" type="main">Dementia Praecox Oder Gruppe Der Schizophrenien</title>
		<author>
			<persName><forename type="first">E</forename><surname>Bleuler</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1911">1911</date>
			<publisher>Deuticke</publisher>
			<pubPlace>Leipzig, Germany</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Koutsouleris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Meisenzahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Davatzikos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Schizophr Bull</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="74" to="84" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Identification of distinct psychosis biotypes using brain-based biomarkers</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Clementz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sweeney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Hamm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page" from="373" to="384" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Resting-state connectivity biomarkers define neurophysiological subtypes of depression</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Drysdale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Grosenick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Downar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="28" to="38" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Prediction of individual response to electroconvulsive therapy via machine learning on structural magnetic resonance imaging data</title>
		<author>
			<persName><forename type="first">R</forename><surname>Redlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Opel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Grotegerd</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Psychiatry</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="557" to="564" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Electroconvulsive therapyinduced brain functional connectivity predicts therapeutic efficacy in patients with schizophrenia: a multivariate pattern recognition study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">X</forename><surname>Jing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NPJ Schizophr</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">21</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review</title>
		<author>
			<persName><forename type="first">G</forename><surname>Orrù</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pettersson-Yeo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Marquand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sartori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mechelli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Biobehav Rev</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1140" to="1152" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Machine learning, statistical learning and the future of biological research in psychiatry</title>
		<author>
			<persName><forename type="first">R</forename><surname>Iniesta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mcguffin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychol Med</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="2455" to="2465" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Predictive analytics in mental health: applications, guidelines, challenges and perspectives</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Nierenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Whitfield-Gabrieli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="37" to="43" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main">Sixty years of placebocontrolled antipsychotic drug trials in acute schizophrenia: systematic review, bayesian meta-analysis, and metaregression of efficacy predictors</title>
		<author>
			<persName><forename type="first">S</forename><surname>Leucht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Leucht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Huhn</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>published online ahead of print May 25, 2017</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title/>
		<idno type="DOI">10.1176/appi.ajp.2017</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Psychiatry</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">A fast diffeomorphic image registration algorithm</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ashburner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroimage</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="95" to="113" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Validity of modulation and optimal settings for advanced voxel-based morphometry</title>
		<author>
			<persName><forename type="first">J</forename><surname>Radua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Canales-Rodríguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pomarol-Clotet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Salvador</forename><forename type="middle">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroimage</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="81" to="90" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers</title>
		<author>
			<persName><forename type="first">N</forename><surname>Koutsouleris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Meisenzahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Borgwardt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="2059" to="2073" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers</title>
		<author>
			<persName><forename type="first">N</forename><surname>Koutsouleris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Riecher-Rössler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Meisenzahl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Schizophr Bull</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="471" to="482" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Assessing and tuning brain decoders: cross-validation, caveats, and guidelines</title>
		<author>
			<persName><forename type="first">G</forename><surname>Varoquaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Raamana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Engemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hoyos-Idrobo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Thirion</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroimage</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="166" to="179" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Robust automated detection of microstructural white matter degeneration in Alzheimer&apos;s disease using machine learning classification of multicenter DTI data</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dyrba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ewers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wegrzyn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e64925</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>EDSD study group</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Generalizable patterns in neuroimaging: how many principal components?</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Nielsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroimage</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="534" to="544" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">A Library for Support Vector Machines</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-J</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><surname>Libsvm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACM Transactions on Intelligent Systems and Technology (TIST)</title>
		<imprint>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">27</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">An overview of statistical learning theory</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Vapnik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Trans Neural Netw</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="988" to="999" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Ensemble based systems in decision making</title>
		<author>
			<persName><forename type="first">R</forename><surname>Polikar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">IEEE Circuits and Systems</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="21" to="45" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Permutation tests for classification: towards statistical significance in image-based studies</title>
		<author>
			<persName><forename type="first">P</forename><surname>Golland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fischl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inf Process Med Imaging</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="330" to="341" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Shum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychiatry Res</title>
		<imprint>
			<biblScope unit="volume">215</biblScope>
			<biblScope unit="page" from="505" to="513" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Review of the efficacy of transcranial magnetic stimulation for auditory verbal hallucinations</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Slotema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Blom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Van Lutterveld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Hoek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">E</forename><surname>Sommer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="101" to="110" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Neurobiological origin of spurious brain morphological changes: a quantitative MRI study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lorio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kherif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ruef</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Brain Mapp</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1801" to="1815" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Speer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Kimbrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Wassermann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1133" to="1141" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Unilateral left prefrontal transcranial magnetic stimulation (TMS) produces intensity-dependent bilateral effects as measured by interleaved BOLD fMRI</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Nahas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lomarev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Roberts</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="712" to="720" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Intensitydependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studied with H215O positron emission tomography: I. Effects of primary motor cortex rTMS</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Speer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Willis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Herscovitch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="818" to="825" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Buckner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Greicius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pascual-Leone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="595" to="603" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pascual-Leone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroimage</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="151" to="160" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Transcranial magnetic stimulation modulates the brain&apos;s intrinsic activity in a frequency-dependent manner</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Eldaief</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Halko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Buckner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pascual-Leone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="21229" to="21234" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Default mode network mechanisms of transcranial magnetic stimulation in depression</title>
		<author>
			<persName><forename type="first">C</forename><surname>Liston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Zebley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="517" to="526" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Inefficient DMN suppression in schizophrenia patients with impaired cognitive function but not patients with preserved cognitive function</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1038/srep21657</idno>
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">21657</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Evidence of a dissociation pattern in default mode subnetwork functional connectivity in schizophrenia</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">14655</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brunoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chaimani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Moffa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Psychiatry</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="143" to="152" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Gaynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Lloyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="477" to="489" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>quiz 489</note>
</biblStruct>

<biblStruct xml:id="b56">
	<monogr>
		<title level="m" type="main">Neurophysiology of rTMS: important caveats when interpreting the results of therapeutic interventions</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Rothwell</surname></persName>
		</author>
		<editor>Platz T, ed. TherapeuticrTMS Neurology</editor>
		<imprint>
			<publisher>Springer International Publishing</publisher>
			<biblScope unit="volume">2016</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<pubPlace>Cham, Heidelberg, New York, Dordrecht, London</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Integrating biomarker information within trials to evaluate treatment mechanisms and efficacy for personalised medicine</title>
		<author>
			<persName><forename type="first">G</forename><surname>Dunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Emsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Landau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Trials</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="709" to="719" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
